<DOC>
	<DOCNO>NCT01082874</DOCNO>
	<brief_summary>Major surgery involve heart common , major heart problem surgery represent large population health problem . Few treatment prevent heart problem around time surgery test . There encourage data suggest small dos Acetyl-Salicylic Acid ( ASA ) Clonidine , two medication , give individually short period major surgery may prevent major heart problem . The POISE-2 Trial large international study test ASA Clonidine prevent heart attack death heart problem around time surgery .</brief_summary>
	<brief_title>PeriOperative ISchemic Evaluation-2 Trial</brief_title>
	<detailed_description>POISE-2 multicentre , international , blind , 2x2 factorial randomize controlled trial acetyl-salicylic acid ( ASA ) clonidine . The primary objective determine impact clonidine versus placebo ASA versus placebo 30-day risk all-cause mortality nonfatal myocardial infarction patient , risk , atherosclerotic disease undergo noncardiac surgery . Patients POISE-2 trial randomly assign one four group : ASA Clonidine together , ASA Clonidine placebo , ASA placebo Clonidine , ASA placebo Clonidine placebo . Research personnel follow patient 30 day post-randomization 1 year post-randomization .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>1 . Are undergoing noncardiac surgery ; 2 . Are ≥ 45 year age ; 3 . Are expected require least overnight hospital admission surgery ; AND 4 . Fulfill one follow 5 criterion : History coronary artery disease History peripheral vascular disease History stroke Undergoing major vascular surgery Any 3 follow 9 criterion : undergoing major surgery ( i.e . intraperitoneal , intrathoracic , retroperitoneal major orthopedic surgery history congestive heart failure transient ischemic attack diabetes currently take oral hypoglycemic agent insulin age ≥ 70 year hypertension serum creatinine &gt; 175 µmol/L ( &gt; 2.0 mg/dL ) history smoke within 2 year surgery undergo urgent/emergent surgery 1 . Consumption ASA within 72 hour prior surgery 2 . Hypersensitivity know allergy ASA clonidine 3 . Systolic blood pressure &lt; 105 mm Hg 4 . Heart rate &lt; 55 beat per minute patient permanent pacemaker 5 . Second third degree heart block without permanent pacemaker 6 . Active peptic ulcer disease gastrointestinal bleeding within previous 6 week 7 . Intracranial hemorrhage document neuroimaging , 6 month prior randomization . This include petechial hemorrhagic transformation primary ischemic stroke 8 . Subarachnoid hemorrhage epidural hematoma unless event occur 6 month prior randomization offend aneurysm arterial lesion repair 9 . Drugeluting coronary stent year prior randomization 10 . Baremetal coronary stent 6 week prior randomization 11 . Thienopyridine ( e.g. , clopidogrel , ticlopidine , prasugrel ) ticagrelor within 72 hour prior surgery ; intent restart thienopyridine ticagrelor first 7 day postop ; currently take alpha2 agonist , alpha methyldopa , monoamine oxidase inhibitor reserpine ; 12 . Planned use first 3 day surgery therapeutic dose anticoagulation therapeutic subcutaneous intravenous antithrombotic agent 13 . Undergoing intracranial surgery , carotid endarterectomy , retinal surgery 14 . Not consent participate POISE2 prior surgery 15 . Previously enrol POISE2 Trial</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Blinded</keyword>
	<keyword>Clonidine</keyword>
	<keyword>acetyl-salicylic acid ( ASA )</keyword>
	<keyword>Perioperative vascular complication</keyword>
	<keyword>Noncardiac surgery</keyword>
</DOC>